Phase 4 N=90 Comparison Between Two Different Dosages of Remifentanil During Colonoscopy
Colonoscopy
Primary: Discharge Time, the Time to Reach a Modified Aldrete Score ≥18 — 0; 0; 2 minutes
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=9,270 Study of Heart and Renal Protection
Kidney Disease, Chronic
Primary: Key Outcome as Per Statistical Analysis Plan = Major Atherosclerotic Events Among All Patients Ever Randomized to Simvastatin Plus Ezetimibe Versus All Patients…
Phase 4 N=489 A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate
Psoriasis
Primary: Number of Patients Experiencing One or More Adverse Events Occurring From Week 0 Through Week 12 — 149; 158 participants
Phase 4 N=58 Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam
Psoriasis
Primary: Number of Participants With a Target Lesion Global Improvement (TLGI) Score of 0, 1, or 2 at Weeks 1, 2, and 4 — 6; 2; 19; 3 participants — p=0.1269
Phase 4 N=17 Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy
Renal Calculus · Kidney Stones
Primary: Pain 'Right Now' — 1.0; 0.9 units on a scale
Phase 4 N=111 Intravenous Ketorolac for Postoperative Pain in Laparoscopic Donor Nephrectomy
Nephrectomy · Laparoscopic Donor Nephrectomy
Primary: Pain 'Right Now' — 2.4; 3.1 units on a scale
Phase 4 N=107 Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia
Fibromyalgia
Primary: Responder Status Based on Patient Global Impression of Change (PGIC) Score at Visit 5 (Week 13) — 5; 26 participants
Phase 4 N=110 Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
Polycystic Ovarian Syndrome · Infertility
Primary: Participants With Cycle Cancellation Due to Risk of Ovarian Hyperstimulation Syndrome (OHSS) Between Weeks 1 - 3 — 1; 0; 1; 0 Participants — p=1.000
Phase 4 N=544 Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome
Erythema Migrans · Post-Lyme Disease Symptoms
Primary: Objective Lyme Disease Manifestations and Post-Lyme Disease Symptoms at 14 Days — 30; 27 participants
Phase 4 N=184 To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.
Cataract
Primary: Endothelial Cell Count Change From Baseline — -7.91; -5.11; -4.92 Percent change from baseline
Phase 4 N=62 Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects
Eyelash Hypotrichosis
Primary: Change From Baseline in Eyelash Length at Week 20 — 5.92; 1.10 Millimeter (mm)
Phase 4 N=114 A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere
Influenza
Primary: Seroconversion — 29; 32; 37; 35 Number of subjects
Phase 4 N=1,066 Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)
Type 2 Diabetes Mellitus (T2DM)
Primary: Proportion of Participants With at Least One Symptomatic Hypoglycemic Event — 0.07; 0.13 proportion of participants — p=0.0005
Phase 4 N=30 Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris
Acne Vulgaris
Primary: Number of Participants Who Were a Success (Subject's Global Assessment of 'Clear' or 'Almost Clear') at Week 12 — 18 participants
Phase 4 N=26 A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products
Acne Vulgaris
Primary: Expert Grader Assessment - Erythema — 0.0; 0.0; 0.4; 2.0 Scores on a Scale